MedlinePlus health matters are frequently reviewed, and links are updated daily. March 13, 2023 • A new drug for Alzheimer's disease, known as lecanemab, got lots of consideration earlier this yr for getting fast-tracked approval primarily based on a clinical trial that included nearly 1,800 individuals. It was probably the most diverse trial for an Alzheimer's treatment thus far, but nonetheless not sufficient to definitively say if the drug is efficient for Black individuals. Unintentional accidents – similar to street visitors crashes, drowning, falls,…